Kiniksa [KNSA] vs Zoetis [ZTS] Detailed Stock Comparison
Kiniksa
NASDAQ
Loading...
Zoetis
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Kiniksa wins in 7 metrics, Zoetis wins in 12 metrics, with 0 ties. Zoetis appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Kiniksa | Zoetis | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 769.80 | 25.16 | Zoetis |
| Price-to-Book Ratio | 5.76 | 13.06 | Kiniksa |
| Debt-to-Equity Ratio | 1.97 | 137.01 | Kiniksa |
| PEG Ratio | -1.54 | 1.44 | Kiniksa |
| EV/EBITDA | 427.37 | 17.80 | Zoetis |
| Profit Margin (TTM) | 0.90% | 27.83% | Zoetis |
| Operating Margin (TTM) | 12.86% | 40.20% | Zoetis |
| EBITDA Margin (TTM) | 12.86% | 40.20% | Zoetis |
| Return on Equity | 1.03% | 52.77% | Zoetis |
| Return on Assets (TTM) | 0.47% | 15.37% | Zoetis |
| Free Cash Flow (TTM) | $25.41M | $2.30B | Zoetis |
| Dividend Yield | N/A | 1.11% | N/A |
| 1-Year Return | 44.16% | -22.95% | Kiniksa |
| Price-to-Sales Ratio (TTM) | 5.39 | 6.91 | Kiniksa |
| Enterprise Value | $2.55B | $70.26B | Zoetis |
| EV/Revenue Ratio | 4.83 | 7.49 | Kiniksa |
| Gross Profit Margin (TTM) | 54.71% | 73.62% | Zoetis |
| Revenue per Share (TTM) | $7 | $21 | Zoetis |
| Earnings per Share (Diluted) | $0.05 | $5.82 | Zoetis |
| Beta (Stock Volatility) | 0.16 | 0.90 | Kiniksa |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Kiniksa vs Zoetis Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Kiniksa | -0.52% | -1.24% | 4.70% | 36.99% | 88.81% | 92.03% |
| Zoetis | 1.51% | 2.03% | -3.94% | -8.02% | -8.26% | -9.96% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Kiniksa | 44.16% | 182.17% | 107.98% | 97.27% | 97.27% | 97.27% |
| Zoetis | -22.95% | -0.64% | -11.49% | 242.10% | 372.17% | 372.17% |
News Based Sentiment: Kiniksa vs Zoetis
Kiniksa
News based Sentiment: MIXED
October was a month of conflicting signals for Kiniksa Pharmaceuticals. While insider and institutional selling raised concerns, positive analyst ratings, a strong balance sheet, and a compelling valuation suggest potential upside. The mixed signals warrant a cautious but optimistic outlook.
Zoetis
News based Sentiment: MIXED
The month featured both positive developments – the CVMP opinion for Portela® and generally positive analyst estimates – alongside negative signals like stock decline, technical warnings, and mixed institutional activity. This creates a balanced, rather than decisively positive or negative, investment narrative.
Performance & Financial Health Analysis: Kiniksa vs Zoetis
| Metric | KNSA | ZTS |
|---|---|---|
| Market Information | ||
| Market Cap | $2.85B | $65.09B |
| Market Cap Category | Mid cap | Large cap |
| 10 Day Avg. Volume | 459,400 | 3,169,830 |
| 90 Day Avg. Volume | 427,353 | 2,720,843 |
| Last Close | $38.29 | $167.10 |
| 52 Week Range | $17.82 - $39.12 | $139.70 - $200.33 |
| % from 52W High | -2.12% | -16.59% |
| All-Time High | $39.12 (Oct 01, 2025) | $249.27 (Dec 27, 2021) |
| % from All-Time High | -2.12% | -32.96% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.44% | 0.04% |
| Quarterly Earnings Growth | 0.44% | 0.15% |
| Financial Health | ||
| Profit Margin (TTM) | 0.01% | 0.28% |
| Operating Margin (TTM) | 0.13% | 0.40% |
| Return on Equity (TTM) | 0.01% | 0.53% |
| Debt to Equity (MRQ) | 1.97 | 137.01 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $6.69 | $11.21 |
| Cash per Share (MRQ) | $4.15 | $3.28 |
| Operating Cash Flow (TTM) | $66.95M | $2.93B |
| Levered Free Cash Flow (TTM) | $39.42M | $2.29B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 1.11% |
| Last 12-Month Dividend | N/A | $1.86 |
Valuation & Enterprise Metrics Analysis: Kiniksa vs Zoetis
| Metric | KNSA | ZTS |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 769.80 | 25.16 |
| Forward P/E | 69.98 | 23.09 |
| PEG Ratio | -1.54 | 1.44 |
| Price to Sales (TTM) | 5.39 | 6.91 |
| Price to Book (MRQ) | 5.76 | 13.06 |
| Market Capitalization | ||
| Market Capitalization | $2.85B | $65.09B |
| Enterprise Value | $2.55B | $70.26B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 4.83 | 7.49 |
| Enterprise to EBITDA | 427.37 | 17.80 |
| Risk & Other Metrics | ||
| Beta | 0.16 | 0.90 |
| Book Value per Share (MRQ) | $6.69 | $11.21 |
Financial Statements Comparison: Kiniksa vs Zoetis
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | KNSA | ZTS |
|---|---|---|
| Revenue/Sales | $137.79M | $2.22B |
| Cost of Goods Sold | $61.66M | $622.00M |
| Gross Profit | $76.13M | $1.60B |
| Research & Development | $19.33M | $157.00M |
| Operating Income (EBIT) | $13.27M | $846.00M |
| EBITDA | $13.62M | $991.00M |
| Pre-Tax Income | $15.57M | $810.00M |
| Income Tax | $7.03M | $179.00M |
| Net Income (Profit) | $8.54M | $631.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | KNSA | ZTS |
|---|---|---|
| Cash & Equivalents | $157.13M | $1.72B |
| Total Current Assets | $355.91M | $5.88B |
| Total Current Liabilities | $97.27M | $3.39B |
| Long-Term Debt | $7.62M | $5.40B |
| Total Shareholders Equity | $457.49M | $4.66B |
| Retained Earnings | $-512.60M | $12.38B |
| Property, Plant & Equipment | $14.20M | $6.36B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | KNSA | ZTS |
|---|---|---|
| Operating Cash Flow | $30.98M | $567.00M |
| Capital Expenditures | $-99,000 | N/A |
| Free Cash Flow | $22.23M | $438.00M |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | $-412,000 | $-443.00M |
Short Interest & Institutional Ownership Analysis
| Metric | KNSA | ZTS |
|---|---|---|
| Shares Short | 2.43M | 9.19M |
| Short Ratio | 5.56 | 3.71 |
| Short % of Float | 0.06% | 0.02% |
| Average Daily Volume (10 Day) | 459,400 | 3,169,830 |
| Average Daily Volume (90 Day) | 427,353 | 2,720,843 |
| Shares Outstanding | 72.52M | 448.47M |
| Float Shares | 33.54M | 442.31M |
| % Held by Insiders | 0.04% | 0.00% |
| % Held by Institutions | 0.93% | 0.99% |
Dividend Analysis & Yield Comparison: Kiniksa vs Zoetis
| Metric | KNSA | ZTS |
|---|---|---|
| Last 12-Month Dividend | N/A | $1.86 |
| Last 12-Month Dividend Yield | N/A | 1.11% |
| 3-Year Avg Annual Dividend | N/A | $1.63 |
| 3-Year Avg Dividend Yield | N/A | 0.24% |
| 3-Year Total Dividends | N/A | $4.90 |
| Ex-Dividend Date | N/A | Apr 21, 2025 |